Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Two Pericardial Bioprostheses in AVR

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients who are going to undergo aortic valve replacement with bioprosthesis~Exclusion Criteria:~* heart failure with severe LV dysfunction (LV EF \<30%)~* active infective endocarditis~* with other critical cardiovascular disease (e.g. acute aortic dissection)~* with other critical comorbities by which the expected life span is less than 1 year~* inadequate participant by the researcher's discretion

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AVALUS group (Type: EXPERIMENTAL): patients who will undergo aortic valve replacement with Avalus bioprosthesis
- CEPME group (Type: ACTIVE_COMPARATOR): patients who will undergo aortic valve replacement with Carpentier-Edwards Perimount Magna Ease bioprosthesis

Based on this trial design, predict the completion outcome and termination type (if applicable).